cyclosporine has been researched along with Eye Diseases in 57 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 22 (38.60) | 18.2507 |
| 2000's | 15 (26.32) | 29.6817 |
| 2010's | 17 (29.82) | 24.3611 |
| 2020's | 3 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Asena, L; Dursun Altınörs, D | 1 |
| Benival, D; Kolhe, S; Rana, D; Rawat, G; Salave, S | 1 |
| Ardern-Jones, MR; Barbara, R; Corden, E; Hossain, PN; Martinez-Falero, BS; O'Driscoll, D; Popiela, MZ; Turnbull, AMJ | 1 |
| Benita, S; Bourges, JL; Garrigue, JS; Gurny, R; Lallemand, F; Schmitt, M | 1 |
| Amrane, M; Baudouin, C; Figueiredo, FC; Garrigue, JS; Ismail, D; Labbé, A; Labetoulle, M; Leonardi, A; Van Setten, G | 1 |
| Halfwassen, C; Scholz, SL; Steuhl, KP; Thomasen, H; Westekemper, H | 1 |
| Boujnah, Y; Burillon, C; Dot, C; El-Chehab, H; Kocaba, V; Mouchel, R | 1 |
| Abramson, AK; Day, A; Menter, MA; Patel, M; Warren, RB | 1 |
| Dutescu, RM; Merkel, OM; Panfil, C; Schrage, N | 1 |
| Brandely Piat, ML; Charles Weber, S; Chast, F; Darrodes, M; Jomaa, K; Kauss Hornecker, M | 1 |
| Borderie, V; Bouheraoua, N; Labbé, A; Laroche, L; Levy, O | 1 |
| Ardern-Jones, MR; Brown, D; Bunker, CB; Creamer, D; Dart, JK; Dziewulski, P; Exton, LS; Lee, HY; Martin, RV; Mohd Mustapa, MF; Philippidou, M; Setterfield, J; Shah, M; Smith, CH; Vercueil, A; Walsh, SA; Watson, KM; Williams, G; Williams, P; Wong, GA | 1 |
| Ahmad, A; Boyd, S; Chang, CN; Dozois, MD; Gu, FX; Hileeto, D; Jones, LW; Liang, H; Liu, S; Ng, DL; Reyad, MM | 1 |
| Novack, GD | 1 |
| Gery, I | 1 |
| Chan, CC; Sen, HN; Tabbara, KF | 1 |
| Chauhan, A; Kapoor, Y | 1 |
| Al-Ghamdi, A; Al-Mohareb, F; Al-Sharif, F; Al-Zahrani, H; Aljurf, M; Ayas, M; Chaudhri, N; Mohammed, SY; Nassar, A; Tabbara, KF | 1 |
| Carmichael, TR; Choonara, YE; Danckwerts, MP; du Toit, LC; Pillay, V | 1 |
| Cury, DB; Moss, AC | 1 |
| Akpek, EK; Stern, M; Utine, CA | 1 |
| da Silva, EC; Dubovi, EJ; Kim, SG; Ledbetter, EC; Schwark, WS | 1 |
| Gordon, KB; McClure, SL; Valentine, J | 1 |
| Behar-Cohen, F; Besseghir, K; Felt-Baeyens, O; Gurny, R; Lallemand, F | 1 |
| Davis, JL; Gilger, BC; Robinson, MR | 1 |
| Acharya, N; Young, L | 1 |
| Akpek, EK; Tatlipinar, S | 1 |
| Batra, M; Fierlbeck, G; Günaydin, I; Kötter, I; Melms, A; Stübiger, N; Vonthein, R | 1 |
| Knipper, A | 1 |
| Anglade, E; Foster, R; Grau, U; Yatscoff, R | 1 |
| Cakir, H; Kaya, V; Perente, I; Tutkun, IT; Utine, CA; Yilmaz, OF | 1 |
| Kashani, S; Mearza, AA | 1 |
| Benchekroun, N; Berraho-Hamani, A; Chaoui, Z; el Aouni, A; Hajji, Z; Ouazzani, B | 1 |
| Benfield, P; Faulds, D; Goa, KL | 1 |
| de Smet, MD; Nussenblatt, RB | 1 |
| Barak, V; BenEzra, D; Kalichman, I; Maftzir, G | 1 |
| Chen, PP; Culbertson, WW; Davis, JL; Palmberg, PF | 1 |
| Dayan, MR; Jayamanne, DG; Porter, R | 1 |
| Baldissera, I; Finkenstedt, G; Höfle, G; Moncayo, R; Pfister, R | 1 |
| Vaden, SL | 1 |
| Burnstine, MA; Elner, SG; Elner, VM | 1 |
| Koziorowska, M; Nizankowska, MH; Popiela, G; Słowik, M | 1 |
| Kellaway, J; Kiang, E; Przepiorka, D; Tesavibul, N; Yee, R | 1 |
| Althaus, C; Kutkuhn, B; Reinhard, T; Reis, A; Sundmacher, R; Voiculescu, A | 1 |
| Carreño, MA; Cuchacovich, M; Gatica, H; Verdaguer, J; Verdaguer, JI; Villarroel, F | 1 |
| Mochizuki, M | 1 |
| Velez, G; Whitcup, SM | 1 |
| Dios, E; Herreras, JM; Saornil, MA | 1 |
| Wiersinga, WM | 1 |
| Binkley, KE; Leznoff, A; Rabinovitch, T; Rootman, DS; Shea, M | 1 |
| Nussenblatt, R | 1 |
| Forrester, JV; Lightman, SL; Towler, HM | 1 |
| Dunn, JP; Jabs, DA | 1 |
| McCluskey, P; Wakefield, D | 1 |
| Nadler, PI; Silverman, MH; Solch, S | 1 |
22 review(s) available for cyclosporine and Eye Diseases
| Article | Year |
|---|---|
Exploring the Therapeutic Potential of Cyclosporine for Ophthalmic Indications by Novel Carrier Systems.
Topics: Administration, Ophthalmic; Cyclosporine; Drug Delivery Systems; Excipients; Eye; Eye Diseases; Humans; Immunosuppressive Agents | 2023 |
Cyclosporine A delivery to the eye: A comprehensive review of academic and industrial efforts.
Topics: Academic Medical Centers; Animals; Cyclosporine; Drug Compounding; Drug Delivery Systems; Drug Industry; Eye Diseases; Humans; Immunosuppressive Agents; Ophthalmic Solutions | 2017 |
[Ocular graft versus host disease : Corneal complications].
Topics: Adrenal Cortex Hormones; Chronic Disease; Combined Modality Therapy; Corneal Diseases; Corneal Ulcer; Cyclosporine; Diagnosis, Differential; Eye Diseases; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Interdisciplinary Communication; Intersectoral Collaboration; Keratoplasty, Penetrating; Limbus Corneae; Ophthalmic Solutions; Tacrolimus | 2017 |
The spectrum of oculocutaneous disease: Part II. Neoplastic and drug-related causes of oculocutaneous disease.
Topics: Aortic Coarctation; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Comorbidity; Cyclosporine; Dermatologic Agents; Eye Abnormalities; Eye Diseases; Eyelid Neoplasms; Humans; Lymphoma, T-Cell, Cutaneous; Melanoma; Mohs Surgery; Multiple Myeloma; Neurocutaneous Syndromes; Retinoids; Sebaceous Gland Neoplasms; Skin Diseases; Skin Neoplasms; Stevens-Johnson Syndrome; Syndrome; Tumor Necrosis Factor-alpha | 2014 |
[Topical cyclosporine in ophthalmology: Pharmacology and clinical indications].
Topics: Administration, Topical; Cyclosporine; Dry Eye Syndromes; Eye Diseases; Humans; Immunosuppressive Agents; Ophthalmic Solutions | 2016 |
Eyes on New Product Development.
Topics: Administration, Ophthalmic; Animals; Antibodies, Monoclonal, Humanized; Clinical Trials as Topic; Cyclosporine; Drug Delivery Systems; Drug Discovery; Eye Diseases; Humans | 2016 |
A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.
Topics: Animals; Blood-Aqueous Barrier; Blood-Retinal Barrier; Cyclosporine; Drug Carriers; Drug Delivery Systems; Eye Diseases; Humans; Infusion Pumps, Implantable; Insulin; Microscopy, Electron, Scanning; Microspheres; Models, Biological; Ophthalmic Solutions; Surface Properties; Vitreous Body | 2010 |
Clinical review: topical ophthalmic use of cyclosporin A.
Topics: Acute Disease; Blepharitis; Conjunctival Diseases; Conjunctivitis, Allergic; Corneal Transplantation; Cyclosporine; Dry Eye Syndromes; Emulsions; Eye Diseases; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Ophthalmic Solutions; Rosacea | 2010 |
Comparative tolerability of systemic treatments for plaque-type psoriasis.
Topics: Acitretin; Cyclosporine; Dermatologic Agents; Drug Combinations; Eye Diseases; Humans; Keratolytic Agents; Liver Cirrhosis; Lymphoproliferative Disorders; Methotrexate; Nausea; Pancytopenia; Pneumonia; Pruritus; Psoriasis; PUVA Therapy; Skin Neoplasms | 2002 |
Cyclosporine A delivery to the eye: a pharmaceutical challenge.
Topics: Administration, Topical; Animals; Cyclosporine; Drug Carriers; Drug Delivery Systems; Eye; Eye Diseases; Humans | 2003 |
Sustained-release drug implants for the treatment of intraocular disease.
Topics: Cyclosporine; Delayed-Action Preparations; Drug Implants; Eye Diseases; Ganciclovir; Glucocorticoids; Humans | 2004 |
Topical ciclosporin in the treatment of ocular surface disorders.
Topics: Conjunctivitis; Cyclosporine; Dry Eye Syndromes; Eye Diseases; Humans; Immunosuppressive Agents; Keratitis; Keratoconjunctivitis; Lichen Planus; Ophthalmic Solutions | 2005 |
Drugs for some common eye disorders.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antioxidants; Carbonic Anhydrase Inhibitors; Cholinergic Agonists; Conjunctivitis, Allergic; Conjunctivitis, Bacterial; Cyclosporine; Diuretics, Osmotic; Dry Eye Syndromes; Eye Diseases; Glaucoma; Glucocorticoids; Humans; Immunosuppressive Agents; Macular Degeneration; Ophthalmic Solutions; Patient Compliance; Patient Selection; Photochemotherapy; Prostaglandins; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Zinc | 2007 |
Next-generation calcineurin inhibitors for ophthalmic indications.
Topics: Animals; Calcineurin Inhibitors; Clinical Trials as Topic; Cyclosporine; Drug Implants; Eye Diseases; Humans | 2007 |
Uses and safety profile of ciclosporin in ophthalmology.
Topics: Administration, Topical; Animals; Cyclosporine; Eye Diseases; Humans; Ophthalmology | 2008 |
Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.
Topics: Arthritis, Rheumatoid; Clinical Trials as Topic; Cyclosporine; Diabetes Mellitus, Type 1; Digestive System Diseases; Eye Diseases; Humans; Immune System Diseases; Nephrotic Syndrome; Nervous System Diseases; Skin Diseases | 1993 |
Clinical use of cyclosporine in ocular disease.
Topics: Autoimmune Diseases; Cyclosporine; Eye Diseases; Humans; Ophthalmic Solutions; Uveitis | 1993 |
Cyclosporine and tacrolimus.
Topics: Animals; Autoimmune Diseases; Cat Diseases; Cats; Cyclosporine; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Eye Diseases; Glomerulonephritis; Graft Rejection; Immunosuppressive Agents; Skin Diseases; Tacrolimus; Transplantation | 1997 |
[Mycophenolatemofetil in ocular immunological disorders. A survey of the literature with 3 case reports].
Topics: Corneal Transplantation; Cyclosporine; Drug Hypersensitivity; Eye Diseases; Female; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Pemphigoid, Benign Mucous Membrane | 1998 |
New developments in sustained release drug delivery for the treatment of intraocular disease.
Topics: Antiviral Agents; Blood-Aqueous Barrier; Cyclosporine; Delayed-Action Preparations; Drug Implants; Eye Diseases; Ganciclovir; Glucocorticoids; Humans; Immunosuppressive Agents; Retinal Diseases; Vitreous Body | 1999 |
Immunosuppressive treatment of Graves' ophthalmopathy.
Topics: Cyclosporine; Eye Diseases; Forecasting; Glucocorticoids; Graves Disease; Humans; Immunoglobulins; Immunosuppression Therapy; Immunosuppressive Agents | 1992 |
The expanding use of immunosuppression in the treatment of non-infectious ocular disease.
Topics: Bromocriptine; Corneal Transplantation; Cyclosporine; Drug Therapy, Combination; Endophthalmitis; Eye Diseases; Humans; Immunosuppression Therapy; Keratoconjunctivitis; Prednisone; Uveitis | 1992 |
5 trial(s) available for cyclosporine and Eye Diseases
| Article | Year |
|---|---|
[Prospective, monocentric, uncontrolled study of efficacy, tolerance and adherence of cyclosporin 0.1 % for severe dry eye syndrome].
Topics: Adult; Aged; Aged, 80 and over; Cyclosporine; Dose-Response Relationship, Drug; Dry Eye Syndromes; Eye Diseases; Female; Humans; Lubricant Eye Drops; Male; Middle Aged; Patient Compliance; Quality of Life; Severity of Illness Index; Sjogren's Syndrome; Tears; Treatment Outcome; Young Adult | 2018 |
Cyclosporin - allergan. Ciclosporin - allergan, cyclosporin ophthalmic emulsion, cyclosporine - Allergan, Restasis.
Topics: Cyclosporine; Drugs, Investigational; Emulsions; Eye Diseases; Humans; Immunosuppressive Agents; Ophthalmic Solutions | 2003 |
[Treatment of non infectious ocular inflammatory disease with low doses of cyclosporin A].
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Chronic Disease; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Eye Diseases; Female; Humans; Immunosuppressive Agents; Inflammation; Male; Middle Aged; Prednisone; Prospective Studies; Radioimmunodetection | 1999 |
Low-dose cyclosporin therapy of ocular inflammation: preliminary report of a long-term follow-up study.
Topics: Blood Pressure; Creatinine; Cyclosporine; Eye Diseases; Follow-Up Studies; Humans; Inflammation; Visual Acuity | 1992 |
Safety and tolerability of two percent cyclosporine (Sandimmune) ophthalmic ointment in normal volunteers.
Topics: Adult; Cohort Studies; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Drug Tolerance; Eye Diseases; Humans; Male; Ointments; Radioimmunoassay; Random Allocation | 1991 |
30 other study(ies) available for cyclosporine and Eye Diseases
| Article | Year |
|---|---|
Application of topical 2% cyclosporine A in inflammatory ocular surface diseases.
Topics: Administration, Topical; Adult; Child; Cyclosporine; Eye Diseases; Humans; Immunosuppressive Agents; Keratitis, Herpetic; Middle Aged; Ophthalmic Solutions; Retrospective Studies | 2023 |
Dupilumab-associated ocular surface disease: presentation, management and long-term sequelae.
Topics: Antibodies, Monoclonal, Humanized; Conjunctivitis; Cyclosporine; Dermatitis, Atopic; Disease Progression; Eye Diseases; Humans; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2021 |
Pan-European survey of the topical ocular use of cyclosporine A.
Topics: Administration, Topical; Cyclosporine; Europe; European Union; Eye Diseases; Humans; Ophthalmic Solutions; Pharmacovigilance; Practice Patterns, Physicians'; Surveys and Questionnaires | 2017 |
Semifluorinated alkanes as a liquid drug carrier system for topical ocular drug delivery.
Topics: Administration, Topical; Alkanes; Animals; Castor Oil; Cornea; Cyclosporine; Drug Carriers; Eye; Eye Diseases; Fluorescein; Fluorine; Glucose; Inflammation; Kinetics; Lactic Acid; Lipids; Rabbits; Solvents | 2014 |
[Cyclosporine eye drops: A 4-year retrospective study (2009-2013)].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Cohort Studies; Corneal Transplantation; Cyclosporine; Drug Prescriptions; Eye Diseases; Female; France; Graft Rejection; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Young Adult | 2015 |
U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.
Topics: Adrenal Cortex Hormones; Adult; Aftercare; Analgesia; Biological Dressings; Critical Pathways; Cyclosporine; Eye Diseases; Female; Female Urogenital Diseases; Fluid Therapy; Forecasting; Humans; Immunoglobulins, Intravenous; Lymphocyte Activation; Male; Male Urogenital Diseases; Mouth Diseases; Nutritional Support; Prognosis; Respiratory Tract Diseases; Skin Care; Skin Irritancy Tests; Stevens-Johnson Syndrome | 2016 |
Prolonged Ocular Retention of Mucoadhesive Nanoparticle Eye Drop Formulation Enables Treatment of Eye Diseases Using Significantly Reduced Dosage.
Topics: Animals; Boronic Acids; Cyclosporine; Dry Eye Syndromes; Eye Diseases; Female; Male; Mice; Mice, Inbred C57BL; N-Acetylneuraminic Acid; Nanoparticles; Ophthalmic Solutions; Rabbits | 2016 |
Robert Burton Nussenblatt, MD, MPH (1948-2016), Physician-Scientist, Leading Ophthalmologist and Exemplary Teacher.
Topics: Antibodies, Monoclonal, Humanized; Cyclosporine; Daclizumab; Eye Diseases; History, 20th Century; History, 21st Century; Humans; Immunoglobulin G; Immunosuppressive Agents; National Eye Institute (U.S.); Ophthalmologists; Physicians; United States; Uveitis | 2017 |
Special Issue in Honor of Robert B. Nussenblatt, MD, MPH.
Topics: Cyclosporine; Eye Diseases; History, 20th Century; History, 21st Century; Humans; Immunosuppressive Agents; National Eye Institute (U.S.); Ophthalmologists; Physicians; T-Lymphocytes; United States; Uveitis | 2017 |
Ophthalmic delivery of Cyclosporine A from Brij-97 microemulsion and surfactant-laden p-HEMA hydrogels.
Topics: Biological Availability; Contact Lenses; Cyclosporine; Delayed-Action Preparations; Diffusion; Drug Carriers; Drug Stability; Drug Storage; Emulsions; Eye Diseases; Hydrogels; Immunosuppressive Agents; Micelles; Plant Oils; Polyethylene Glycols; Polyhydroxyethyl Methacrylate; Surface-Active Agents | 2008 |
Ocular findings after allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Child; Cyclosporine; Eye Diseases; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Intraocular Pressure; Male; Methotrexate; Middle Aged; Ophthalmoscopy; Retrospective Studies; Transplantation, Homologous; Visual Acuity | 2009 |
Ocular manifestations in a community-based cohort of patients with inflammatory bowel disease.
Topics: Acute Disease; Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Cohort Studies; Cyclosporine; Dry Eye Syndromes; Eye Diseases; Female; Humans; Inflammatory Bowel Diseases; Infliximab; Male; Mesalamine; Methotrexate; Middle Aged; Steroids; Treatment Outcome | 2010 |
Frequency of spontaneous canine herpesvirus-1 reactivation and ocular viral shedding in latently infected dogs and canine herpesvirus-1 reactivation and ocular viral shedding induced by topical administration of cyclosporine and systemic administration of
Topics: Administration, Ophthalmic; Adrenal Cortex Hormones; Animals; Antibodies, Viral; Cyclosporine; DNA, Viral; Dog Diseases; Dogs; Eye Diseases; Herpesviridae Infections; Herpesvirus 1, Canid; Immunosuppressive Agents; Male; Neutralization Tests; Polymerase Chain Reaction; Virus Latency | 2012 |
Novel approaches to ocular drug delivery.
Topics: Animals; Cyclosporine; Drug Administration Routes; Drug Delivery Systems; Eye; Eye Diseases; Genetic Therapy; Humans; Prodrugs; Prostheses and Implants | 2004 |
CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications--results of a retrospective analysis of 117 cases.
Topics: Adolescent; Adult; Autonomic Nervous System Diseases; Azathioprine; Behcet Syndrome; Cohort Studies; Comorbidity; Cyclosporine; Disease Progression; Eye Diseases; Female; Germany; Humans; Immunosuppressive Agents; Incidence; Interferon-alpha; Male; Middle Aged; Prevalence; Retrospective Studies; Severity of Illness Index | 2006 |
[Immunosuppressants for genetic disorders--drug treatment of choice].
Topics: Animals; Autoimmune Diseases; Cyclosporine; Eye Diseases; Horse Diseases; Horses; Immunosuppressive Agents | 2006 |
Management of ocular complications of Vogt-Koyanagi-Harada syndrome.
Topics: Adolescent; Cyclosporine; Drug Therapy, Combination; Eye Diseases; Female; Fluorescein Angiography; Glucocorticoids; Humans; Immunosuppressive Agents; Optic Nerve Diseases; Retinal Detachment; Tomography, Optical Coherence; Triamcinolone Acetonide; Ultrasonography; Uveomeningoencephalitic Syndrome; Vitreous Body | 2009 |
[Outcome of Behçet disease in ophthalmologic practice in Morocco].
Topics: Adult; Behcet Syndrome; Chlorambucil; Cyclosporine; Eye Diseases; Female; Humans; Male; Morocco; Prednisone; Prognosis; Retinal Diseases; Time Factors; Uveitis | 1995 |
Serum levels of interleukin-2 receptor in ocular Behçet's disease.
Topics: Behcet Syndrome; Cyclosporine; Drug Combinations; Eye; Eye Diseases; Humans; Methylprednisolone; Pars Planitis; Receptors, Interleukin-2; Reference Values | 1993 |
Management of overfiltering and leaking blebs with autologous blood injection.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Blood; Chorioretinitis; Corneal Edema; Cyclosporine; Eye Diseases; Glaucoma, Angle-Closure; Humans; Immunosuppressive Agents; Injections; Intraocular Pressure; Male; Middle Aged; Pyrimethamine; Steroids; Toxoplasmosis, Ocular; Trabeculectomy; Visual Acuity; Vitreous Body | 1996 |
Cyclosporin-induced trichomegaly of accessory lashes as a cause of ocular irritation.
Topics: Cyclosporine; Eye Diseases; Eyelashes; Hair Diseases; Humans; Immunosuppressive Agents; Keratins; Kidney Transplantation; Male; Microscopy, Electron, Scanning; Middle Aged | 1996 |
Endocrine ophthalmopathy in a patient under continuous immunosuppressive therapy after cardiac transplantation.
Topics: Adult; Cyclosporine; Eye Diseases; Female; Graves Disease; Heart Transplantation; Humans; Immunosuppressive Agents; Intraocular Pressure; Prednisolone; Tomography, Emission-Computed | 1995 |
Orbital fibroblast chemokine modulation: effects of dexamethasone and cyclosporin A.
Topics: Anti-Inflammatory Agents; Blotting, Northern; Cells, Cultured; Chemokine CCL2; Chemokines; Cyclosporine; Dexamethasone; Enzyme-Linked Immunosorbent Assay; Eye Diseases; Fibroblasts; Humans; Immunosuppressive Agents; Interleukin-8; RNA, Messenger | 1998 |
[Bilateral isolated posterior scleritis].
Topics: Adult; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Exophthalmos; Eye Diseases; Eye Neoplasms; Humans; Hyperemia; Immunosuppressive Agents; Male; Pain; Remission Induction; Scleritis; Steroids; Ultrasonography | 1997 |
The use of topical cyclosporin A in ocular graft-versus-host-disease.
Topics: Administration, Topical; Adult; Bone Marrow Transplantation; Cyclosporine; Eye Diseases; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Transplantation, Homologous | 1998 |
[Immunotherapy in the eye].
Topics: Child; Cyclosporine; Eye Diseases; Female; Humans; Immunosuppressive Agents; Immunotherapy | 1999 |
Conjunctival biopsy in the diagnosis of ocular sarcoidosis.
Topics: Adolescent; Adult; Biopsy; Conjunctiva; Cyclosporine; Eye Diseases; Female; Humans; Immunosuppressive Agents; Middle Aged; Sarcoidosis | 2001 |
Cyclosporine in the treatment of nonmicrobial inflammatory ophthalmic disease.
Topics: Adolescent; Adult; Aged; Choroiditis; Corneal Transplantation; Cyclosporine; Eye Diseases; Female; Follow-Up Studies; Graft Rejection; Humans; Inflammation; Male; Middle Aged; Ophthalmia, Sympathetic; Prognosis; Uveitis, Intermediate | 1992 |
Ocular microvasculopathy after bone marrow transplantation.
Topics: Bone Marrow Transplantation; Cyclosporine; Eye Diseases; Humans; Whole-Body Irradiation | 1992 |
Cyclosporine: a therapy in inflammatory eye disease.
Topics: Adult; Aged; Arthritis, Reactive; Blood Pressure; Creatinine; Cyclosporine; Eye Diseases; Female; Follow-Up Studies; Hirsutism; Humans; Male; Middle Aged; Recurrence; Sarcoidosis; Treatment Outcome; Tremor; Uveitis; Uveomeningoencephalitic Syndrome; Visual Acuity | 1991 |